Sign in
TDACW Stock Price, Chart, Stats & News
Translational Development Acquisition Corp.
Save
264.53M
Market cap
–
Current P/E
–
Forward P/E
TDACW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 4.20% |
Operating margin | -165.48% |
Pretax margin | 860.04% |
Net margin | 860.04% |
Effective tax rate | – |
ROA | 2.64% |
ROE | 2.78% |
D/E | 0.00x |
Interest coverage ratio | 15.23x |
TDACW valuation
P/E | – |
P/S | 418.91x |
P/B | 1.05x |
P/CF | -74.24x |
P/FCF | -94.28x |
P/OCF | -74.24x |
PEG | 1.83x |
EV multiple | -252.63x |
About
Translational Development Acquisition Corp., established in 2022 and headquartered in New York, New York, currently possesses no significant business operations.
Similar securities
Based on sector and market capitalization
Report issue